Kamada (KMDA) Net Margin Growth (1y) (2013 - 2026)

Kamada (KMDA) Net Margin Growth (1y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 364.00
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -82.00
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -4,395.00
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -538.00
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 9,850.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2,292.00
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -146.00
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn -634.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -634.00
Dec 31, 2025 1,037.00
Sep 30, 2025 616.00
Jun 30, 2025 0.00
Mar 31, 2025 1,438.00
Dec 31, 2024 -1,085.00
Sep 30, 2024 116.00
Jun 30, 2024 -484.00
Mar 31, 2024 666.00
Dec 31, 2023 655.00
Sep 30, 2023 850.00
Jun 30, 2023 -1,189.00
Mar 31, 2023 -651.00
Dec 31, 2022 2,246.00
Sep 30, 2022 -377.00
Jun 30, 2022 1,275.00
Mar 31, 2022 -428.00
Dec 31, 2021 -2,048.00
Sep 30, 2021 -1,558.00
Jun 30, 2021 -647.00